Eris Lifesciences
Tracked across 3 events · 35 articles · First seen Mar 20, 2026 · Last active Sep 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Cohance is the investor and parent company, increasing stakes in NJ Bio and Aruka Bio to strengthen its ADC strategy. The investment is expected to enhance its integrated capabilities and market position.
Sep 03, 2026 · 6 articles
Business
Impact: Eris Lifesciences has tied up with Natco Pharma for the marketing of generic semaglutide, forming an alliance to compete in the Indian market.
Mar 20, 2026 · 8 articles
Business
Impact: Eris Lifesciences competes in the insulin glargine market and may be affected by Awiqli's entry.
Jul 09, 2026 · 21 articles
ERGEN INTELLIGENCE
Track Eris Lifesciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard